Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients: A phase 2 trial

Author： Abou-Jawde Rony   Reed Janice   Kelly Megan   Walker Esteban   Andresen Steven   Baz Rachid   Karam Mary   Hussein Mohamad  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.23, Iss.2, 2006-06, pp. : 263-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma

By Held Lauren A.   Rizzieri David   Long Gwynn D.   Gockerman Jon P.   Diehl Louis F.   Castro Carlos M. de   Moore Joseph O.   Horwitz Mitchell E.   Chao Nelson J.   Gasparetto Cristina  

Cancer Investigation, Vol. 31, Iss. 3, 2013-03 ,pp. : 172-176

Informa Healthcare

Access to resources Recommend Favorite

Arsenic trioxide/ascorbic acid therapy in patients with refractory metastatic colorectal carcinoma: A clinical experience

By Subbarayan Pochi R.   Lima Mayra   Ardalan Bach  

Acta Oncologica, Vol. 46, Iss. 4, 2007-01 ,pp. : 557-561

Informa Healthcare

Access to resources Recommend Favorite

Phase II Trial of rhIL-6 (Interleukin-6) Prior to and Concurrently with VAD (Vincristine, Doxorubicin and Dexamethasone) Chemotherapy for Patients with Multiple Myeloma

By Young R.I.   Ranson M.   Chang J.   Lord B.   Testa N.   Scarffe J.H.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 307-311

Elsevier

Access to resources Recommend Favorite

Combination Therapy with Arsenic Trioxide for Hematological Malignancies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 6, 2010-07 ,pp. : 504-510

Bentham Science Publishers

Access to resources Recommend Favorite

Arsenic trioxide: A new immunomodulatory agent in the management of multiple myeloma

By Hussein Mohamad  

Medical Oncology, Vol. 18, Iss. 4, 2001-12 ,pp. : 239-242

Humana Press, Inc

Access to resources Recommend Favorite